AMCR vs PSNYW

AMCR's deterministic health score is stable with a Piotroski F-Score of 6/9, indicating moderate financial strength, though the absence of an Altman Z-Score limits distress risk assessment. The stock trades at a significant premium to its Graham Number ($29.87) and intrinsic value ($10.92), supported by a high forward P/E of 9.96 despite a trailing P/E of 28.38, suggesting optimism around earnings recovery. While revenue growth is robust (71.3% YoY), earnings growth is negative (-14.4% YoY), and the dividend payout ratio is dangerously high at 169.44%, raising sustainability concerns. Analysts are strongly bullish with a $55.01 target price, but weak recent earnings beats (1 of last 4) and bearish technicals (0/100) create conflicting signals.

The deterministic health profile is critically weak, highlighted by a Piotroski F-Score of 3/9 and a complete absence of a Graham Number due to negative earnings and equity. The company is facing a severe liquidity crisis with a current ratio of 0.43 and a quick ratio of 0.21, indicating an inability to meet short-term obligations. Most alarmingly, the gross margin is -32.68%, meaning the company loses money on every vehicle produced before operating expenses. While revenue growth remains positive at 26.10%, the negative Price/Book ratio (-0.06) and bearish technical trend (0/100) suggest a high risk of insolvency or massive dilution.